BioLife Accounts Payable from 2010 to 2024

BLFS Stock  USD 27.06  0.29  1.08%   
BioLife Solutions Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount BioLife Solutions owes to suppliers or vendors for products or services received but not yet paid for. It represents BioLife Solutions' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1990-06-30
Previous Quarter
4.2 M
Current Value
3.8 M
Quarterly Volatility
3.4 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0014 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Latest BioLife Solutions' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of BioLife Solutions over the last few years. An accounting item on the balance sheet that represents BioLife Solutions obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioLife Solutions are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. BioLife Solutions' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

BioLife Accounts Payable Regression Statistics

Arithmetic Mean3,819,208
Geometric Mean1,619,682
Coefficient Of Variation134.54
Mean Deviation3,901,622
Median867,070
Standard Deviation5,138,523
Sample Variance26.4T
Range15.2M
R-Value0.72
Mean Square Error13.7T
R-Squared0.52
Significance0
Slope826,590
Total Sum of Squares369.7T

BioLife Accounts Payable History

20247.3 M
20236.9 M
202215.4 M
202114.9 M
20203.7 M
20193.1 M
2018720 K

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable6.9 M7.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.